0001225208-14-025381.txt : 20141217
0001225208-14-025381.hdr.sgml : 20141217
20141217181517
ACCESSION NUMBER: 0001225208-14-025381
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20141215
FILED AS OF DATE: 20141217
DATE AS OF CHANGE: 20141217
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: BARD C R INC /NJ/
CENTRAL INDEX KEY: 0000009892
STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841]
IRS NUMBER: 221454160
STATE OF INCORPORATION: NJ
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 730 CENTRAL AVE
CITY: MURRAY HILL
STATE: NJ
ZIP: 07974
BUSINESS PHONE: 9082778000
MAIL ADDRESS:
STREET 1: 730 CENTRAL AVENUE
CITY: MURRAY HILL
STATE: NJ
ZIP: 07974
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: DeFord John A
CENTRAL INDEX KEY: 0001403373
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-06926
FILM NUMBER: 141293655
MAIL ADDRESS:
STREET 1: C R BARD INC
STREET 2: 730 CENTRAL AVENUE
CITY: MURRAY HILL
STATE: NJ
ZIP: 07974
4
1
doc4.xml
X0306
4
2014-12-15
0000009892
BARD C R INC /NJ/
BCR
0001403373
DeFord John A
C/O C. R. BARD, INC.
730 CENTRAL AVENUE
MURRAY HILL
NJ
07974
1
Sr. VP Sci Tech and Clin Afrs
Common Stock
2014-12-15
4
F
0
2656.0000
166.6300
D
24871.5474
D
Common Stock
2014-12-16
4
M
0
5626.0000
84.5750
A
30497.5474
D
Common Stock
2014-12-16
4
S
0
400.0000
168.5025
D
30097.5474
D
Common Stock
2014-12-16
4
S
0
1547.0000
166.6929
D
28550.5474
D
Common Stock
2014-12-16
4
S
0
3679.0000
167.6862
D
24871.5474
D
Common Stock
35.3600
I
401(k) Plan
Option (Right to Buy)
84.5750
2014-12-16
4
M
0
5626.0000
0.0000
D
2021-12-14
Common Stock
5626.0000
5627.0000
D
Shares withheld to pay taxes upon vesting of restricted stock units granted under the Company's 2003 Long Term Incentive Plan.
Includes 0.2256 shares acquired under the Company's Dividend Reinvestment Plan from February 11, 2014 to October 31, 2014.
Option exercise and sales are pursuant to a previously disclosed 10b5-1 plan.
Represents the weighted average sales price for price increments ranging from $168.15 to $168.94. The Reporting Person undertakes to provide, upon request by the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer, full information regarding the number of shares sold at each separate price for all transactions reported on this Form 4.
Represents the weighted average sales price for price increments ranging from $166.13 to $167.07. The Reporting Person undertakes to provide, upon request by the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer, full information regarding the number of shares sold at each separate price for all transactions reported on this Form 4.
Represents the weighted average sales price for price increments ranging from $167.14 to $168.13. The Reporting Person undertakes to provide, upon request by the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer, full information regarding the number of shares sold at each separate price for all transactions reported on this Form 4.
Includes 20.921 shares acquired under the Company's 401(k) Plan from February 4, 2014 to October 31, 2014.
Options granted under 2003 Long Term Incentive Plan of C. R. Bard, Inc. (as Amended and Restated).
Of this option grant 5,627 options are fully vested, and the remaining 5,627 options will vest on December 14, 2015.
Myra McGinley, Attorney-in-Fact
2014-12-17